Barclays analyst Benjamin Budish lowered the firm’s price target on AllianceBernstein (AB) to $39 from $40 and keeps an Equal Weight rating on the shares following the Q3 report. The company’s earnings beat consensus estimates flow flows for the quarter were negative, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AB:
- AllianceBernstein’s Neutral Rating Maintained Amidst Strategic Expansion and Performance Challenges
- AllianceBernstein Reports Strong Q3 2025 Results
- AllianceBernstein reports Q3 adjusted EPS 86c, consensus 85c
- AllianceBernstein makes strategic investment focused on Asian insurance market
- AllianceBernstein price target lowered to $40 from $42 at Barclays
